Bain Capital Life Sciences

• Kailera Therapeutics

  Series B, Oct 14, 2025

• Abcuro

  Series C, Feb 12, 2025

• Kailera Therapeutics

  Series A, Lead, Oct 1, 2024

• Abcuro

  Lead, Aug 17, 2023

• Rivus Pharmaceuticals

  Series B, Sep 22, 2022

• Areteia Therapeutics

  Lead, Jul 13, 2022

• AavantiBio

  Series A, Oct 22, 2020

• Atea Pharmaceuticals

  Series D-1, Oct 1, 2020

• Annexon

  Series D, Jul 1, 2020

• Atea Pharmaceuticals

  Series D, May 1, 2020

• JenaValve Technology

  Venture, Lead, Feb 5, 2020

• Annexon

  Series C, $30M, Dec 1, 2018

Sources: globenewswire.com, biospace.com, baincapital.com, pharmaphorum.com, prnewswire.com, news.crunchbase.com, news.google.com, sec.gov, pulse2.com